We use cookies to customise content for your subscription and for analytics. If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
FSA has informed firms that a judgment is expected from the European Court of Justice on 1 March, addressing whether insurance companies are allowed to use gender as a pricing factor in certain circumstances
